512. Interim Results of a Prospective Cohort Study to Monitor the Emergence of Resistance in Immunocompromised Non-Hospitalized Patients With COVID-19 Who Were Treated with Sotrovimab in Great Britain: LUNAR Study 

BACKGROUND: Immunocompromised (IC) patients are at risk of adverse COVID-19 outcomes. The risk of treatment emergent resistance may be high in this population. This study investigated clinical and virological outcomes in sotrovimab-treated IC patients in Great Britain while the Omicron variant was p...

Descripción completa

Detalles Bibliográficos
Autores principales: Breuer, Judith, Drysdale, Myriam, Walker, Jill, Han, Jennifer, Gorczycka, Magdalena, Aylott, Alicia, Van Dyke, Melissa K, Birch, Helen, McKie, Elizabeth, Lowe, David M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678156/
http://dx.doi.org/10.1093/ofid/ofad500.581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678156/
http://dx.doi.org/10.1093/ofid/ofad500.581

Ejemplares similares